Substantia Nigra: Site of Anticonvulsant Activity Mediated by γ-Aminobutyric Acid

American Association for the Advancement of Science (AAAS) - Tập 218 Số 4578 - Trang 1237-1240 - 1982
Michael J. Iadarola1, Karen Gale1
1Department of Pharmacology, Georgetown University Schools of Medicine and Dentistry, Washington, D.C. 20007

Tóm tắt

Localization of the anatomic substrate for anticonvulsant activity mediated by γ-aminobutyric acid (GABA) was examined using intracerebral injections of GABA agonists. Blockade of tonic hindlimb extension in the maximal electroshock test and blockade of tonic and clonic seizures produced by pentylenetetrazole and bicuculline were obtained by elevating GABA in the ventral midbrain tegmentum. Elevation of GABA in forebrain and hindbrain areas had no effect on convulsant activity. Blockade of tonic and clonic seizures was also obtained after microinjections of the direct GABA receptor agonist, muscimol, into the midbrain. The substantia nigra was identified as the critical midbrain site for GABA-mediated anticonvulsant activity. Local injection of GABA agonists into the midbrain provided seizure protection without a widespread augmentation of GABA-mediated activity throughout the brain and without impairing either alertness or motor function. Synapses in the substantia nigra appear to represent an important control mechanism for inhibiting the propagation of generalized convulsions.

Từ khóa


Tài liệu tham khảo

ANDERSON, M, ELECTROPHYSIOLOGICAL EVIDENCE FOR BRANCHING NIGRAL PROJECTIONS TO THALAMUS AND SUPERIOR COLLICULUS, BRAIN RESEARCH 137: 361 (1977).

BERGMANN, F, A LOW THRESHOLD CONVULSIVE AREA IN RABBITS MESENCEPHALON, ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 15: 683 (1963).

CASU, M, INTRA-CEREBRAL INJECTION OF GAMMA VINYL GABA - METHOD FOR MEASURING RATES OF GABA SYNTHESIS IN SPECIFIC BRAIN-REGIONS INVIVO, LIFE SCIENCES 29: 681 (1981).

CHILDS, J.A., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 7: 196 (1981).

DICHIARA, G, EVIDENCE FOR A GABAERGIC PROJECTION FROM THE SUBSTANTIA NIGRA TO THE VENTROMEDIAL THALAMUS AND TO THE SUPERIOR COLLICULUS OF THE RAT, BRAIN RESEARCH 176: 273 (1979).

FAETH, W.H., EPILEPSIA 3: 37 (1954).

FARIELLO, R.G., SUBSTANTIA NIGRA AND PENTYLENETETRAZOL THRESHOLD IN RATS - CORRELATION WITH STRIATAL DOPAMINE METABOLISM, EXPERIMENTAL NEUROLOGY 65: 202 (1979).

DRUG-INDUCED ELEVATION OF GABA AFTER INTRA-CEREBRAL MICRO-INJECTION - SITE OF ANTICONVULSANT ACTION, EUROPEAN JOURNAL OF PHARMACOLOGY 68: 233 (1980).

10.1126/science.6768130

GALE K unpublished data.

GARANT, D.S., IDENTIFICATION OF SUBSTANTIA NIGRA AS THE MIDBRAIN SITE ASSOCIATED WITH GABA-MEDIATED ANTICONVULSANT ACTIVITY, FEDERATION PROCEEDINGS 41: 1064 (1982).

GIBBS, F.A., The convulsion threshold of various parts of the cat's brain, ARCHIVES OF NEUROLOGY AND PSYCHIATRY 35: 109 (1936).

GLOOR, P, GENERALIZED CORTICO-RETICULAR EPILEPSIES - SOME CONSIDERATIONS ON PATHOPHYSIOLOGY OF GENERALIZED BILATERALLY SYNCHRONOUS SPIKE AND WAVE DISCHARGE, EPILEPSIA 9: 249 (1968).

GRACE, A.A., PARADOXICAL GABA EXCITATION OF NIGRAL DOPAMINERGIC CELLS - INDIRECT MEDIATION THROUGH RETICULATA INHIBITORY NEURONS, EUROPEAN JOURNAL OF PHARMACOLOGY 59: 211 (1979).

HAYASHI, T, JAPANESE JOURNAL OF PHYSIOLOGY 3: 46 (1953).

HAYASHI, T, JAPANESE JOURNAL OF PHYSIOLOGY 3: 306 (1953).

HEATH, R, BRAIN-FUNCTION IN EPILEPSY - MIDBRAIN, MEDULLARY, AND CEREBELLAR INTERACTION WITH ROSTRAL FOREBRAIN, JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 39: 1037 (1976).

IADAROLA, M.J., ADV EPILEPTOL: 449 (1980).

IADAROLA, M.J., EVALUATION OF INCREASES IN NERVE TERMINAL-DEPENDENT VS NERVE TERMINAL-INDEPENDENT COMPARTMENTS OF GABA INVIVO, BRAIN RESEARCH BULLETIN 5: 13 (1980).

IADAROLA, M.J., DIFFERENTIAL EFFECTS OF N-DIPROPYLACETATE AND AMINO-OXYACETIC ACID ON GAMMA-AMINOBUTYRIC ACID LEVELS IN DISCRETE AREAS OF RAT-BRAIN, JOURNAL OF NEUROCHEMISTRY 33: 1119 (1979).

JINNAI, D, ACTA MED OKAYAMA 8: 26 (1954).

KILPATRICK, I.C., EXP BRAIN RES 40: 55 (1980).

KREINDLER, A, ELECTROCLINICAL FEATURES OF CONVULSIONS INDUCED BY STIMULATION OF BRAIN STEM, JOURNAL OF NEUROPHYSIOLOGY 21: 430 (1958).

KUPFERBERG H COMMUNICATION.

LOSCHER, W, EFFECT OF INHIBITORS OF GABA AMINOTRANSFERASE ON THE METABOLISM OF GABA IN BRAIN-TISSUE AND SYNAPTOSOMAL FRACTIONS, JOURNAL OF NEUROCHEMISTRY 36: 1521 (1981).

LOSCHER, W, A COMPARATIVE-STUDY OF THE PHARMACOLOGY OF INHIBITORS OF GABA-METABOLISM, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 315: 119 (1980).

MELDRUM, B.S., CLIN NEUROPHARMACOL 6: 293 (1982).

MELDRUM, B.S., INTERNATIONAL REVIEW OF NEUROBIOLOGY 17: 1 (1975).

OLIANAS, M.C., STRIATAL DOPAMINERGIC FUNCTION IS MEDIATED BY INHIBITION OF A NIGRAL, NON-DOPAMINERGIC NEURONAL SYSTEM VIA A STRIO-NIGRAL GABAERGIC PATHWAY, EUROPEAN JOURNAL OF PHARMACOLOGY 49: 233 (1978).

OLSEN, R.W., STUDIES ON NEUROPHARMACOLOGICAL ACTIVITY OF BICUCULLINE AND RELATED COMPOUNDS, BRAIN RESEARCH 102: 283 (1976).

SCHECHTER, P.J., ANTI-SEIZURE ACTIVITY OF GAMMA-ACETYLENIC GAMMA-AMINOBUTYRIC ACID - CATALYTIC IRREVERSIBLE INHIBITOR OF GAMMA-AMINOBUTYRIC ACID TRANSAMINASE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 201: 606 (1977).

TOWER, D.B., GABA NERVOUS SYSTEM: 461 (1976).

WASZCZAK, B.L., EFFECTS OF MUSCIMOL AND PICROTOXIN ON SINGLE UNIT-ACTIVITY OF SUBSTANTIA NIGRA NEURONS, BRAIN RESEARCH 188: 185 (1980).

WOODBURY, L.A., DESIGN AND USE OF A NEW ELECTROSHOCK SEIZURE APPARATUS, AND ANALYSIS OF FACTORS ALTERING SEIZURE THRESHOLD AND PATTERN, ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 92: 97 (1952).